SAN FRANCISCO, Aug. 6, 2025 /PRNewswire/ — Eko Health, a leader in AI-powered cardiac and pulmonary care, announced the expansion of its Clinical Advisory Board to support the company’s mission to transform how heart and lung disease are detected and managed. The board will provide strategic guidance on Eko’s clinical research and implementation strategy, inform product development, and help ensure the company’s work continues to advance equitable access to early disease detection.

Read more here.